RBC Europe’s Advent Technologies ADN Stock Holding History

RBC Europe’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20	Closed	-$5.31K	–	635
2021 Q3	$5.31K	Hold	20	–	–	﹤0.01%	1038
2021 Q2	$5.88K	Hold	20	–	–	﹤0.01%	1035
2021 Q1	$8.17K	Buy	+20	New	+$9.05K	﹤0.01%	944

Other funds holding ADN

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

RBC Europe's ADN Position: Q4 2021 in Review

RBC Europe sold out of Advent Technologies (ADN) in Q4 2021, closing a stake of 20 shares — an estimated $5.31K sold.

RBC Europe first reported a position in ADN in Q1 2021 and held it in 3 quarters. The position peaked at $8.17K in Q1 2021. 51 funds tracked by Wall St. Rank hold ADN as of Q4 2021.

RBC Europe reported no remaining Advent Technologies position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 20 Advent Technologies shares in Q4 2021, an estimated $5.31K.
RBC Europe first reported a position in Advent Technologies in Q1 2021 and held it in 3 quarters.
RBC Europe's Advent Technologies position peaked at $8.17K in Q1 2021.
51 funds tracked by Wall St. Rank held Advent Technologies as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.